DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,058 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,566,564 | +127.2% | 41,600 | +118.2% | 0.08% | +22.7% |
| Q2 2023 | $4,651,595 | -4.8% | 19,068 | +3.9% | 0.07% | -16.5% |
| Q1 2023 | $4,886,110 | -67.4% | 18,358 | -72.8% | 0.08% | -38.3% |
| Q4 2022 | $14,983,688 | +4.2% | 67,588 | +26.0% | 0.13% | -1.5% |
| Q3 2022 | $14,374,048 | +401.1% | 53,656 | +374.3% | 0.13% | +106.3% |
| Q2 2022 | $2,868,245 | +23.4% | 11,312 | +63.2% | 0.06% | +16.7% |
| Q1 2022 | $2,324,000 | -4.9% | 6,931 | -6.6% | 0.05% | -11.5% |
| Q4 2021 | $2,445,000 | +13.6% | 7,421 | +5.0% | 0.06% | -3.2% |
| Q3 2021 | $2,152,000 | +38.3% | 7,065 | +21.9% | 0.06% | +34.0% |
| Q2 2021 | $1,556,000 | +83.7% | 5,796 | +54.2% | 0.05% | +62.1% |
| Q1 2021 | $847,000 | +551.5% | 3,759 | +540.4% | 0.03% | +480.0% |
| Q4 2020 | $130,000 | +34.0% | 587 | +30.4% | 0.01% | -54.5% |
| Q3 2020 | $97,000 | +21.2% | 450 | 0.0% | 0.01% | +22.2% |
| Q2 2020 | $80,000 | +29.0% | 450 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $62,000 | -92.2% | 450 | -13.6% | 0.01% | 0.0% |
| Q4 2019 | $800,000 | +1130.8% | 521 | +15.8% | 0.01% | +12.5% |
| Q3 2019 | $65,000 | -56.7% | 450 | -57.1% | 0.01% | -55.6% |
| Q2 2019 | $150,000 | +120.6% | 1,050 | +103.1% | 0.02% | +100.0% |
| Q1 2019 | $68,000 | +9.7% | 517 | -13.8% | 0.01% | -50.0% |
| Q4 2018 | $62,000 | +933.3% | 600 | +852.4% | 0.02% | +350.0% |
| Q2 2018 | $6,000 | 0.0% | 63 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $6,000 | -33.3% | 63 | -37.0% | 0.00% | -62.5% |
| Q3 2017 | $9,000 | +12.5% | 100 | 0.0% | 0.01% | +166.7% |
| Q2 2017 | $8,000 | -27.3% | 100 | -19.4% | 0.00% | -50.0% |
| Q1 2017 | $11,000 | +37.5% | 124 | +24.0% | 0.01% | -25.0% |
| Q3 2016 | $8,000 | -20.0% | 100 | 0.0% | 0.01% | -20.0% |
| Q2 2016 | $10,000 | -81.1% | 100 | -84.0% | 0.01% | -93.0% |
| Q3 2015 | $53,000 | +15.2% | 625 | +15.7% | 0.14% | +85.7% |
| Q2 2015 | $46,000 | +21.1% | 540 | +20.0% | 0.08% | +26.2% |
| Q1 2015 | $38,000 | – | 450 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |